Nabi Zaheer, Chaithanya Manchu, Inavolu Pradev, Ramchandani Mohan, Reddy Palle Manohar, Sayyed Mahiboob, Basha Jahangeer, Pal Partha, Sekharan Anuradha, Goud Rajesh, Reddy Praveen, Jagtap Nitin, Kotla Rama, Kalpala Rakesh, Darisetty Santhosh, Lakhtakia Sundeep, Rao Guduru Venkat, Tandan Manu, Gupta Rajesh, Devarasetti Rangarao, Rebala Pradeep, Shetty Mahesh, Reddy D Nageshwar
Asian Institute of Gastroenterology, 6-3-661, Hyderabad, 500 082, India.
Indian J Gastroenterol. 2024 Oct;43(5):1012-1020. doi: 10.1007/s12664-024-01635-w. Epub 2024 Aug 1.
Endoscopic sub-mucosal dissection (ESD) is an established endoscopic modality for the management of colorectal polyps. However, there are no studies regarding the outcomes of ESD from India. In this study, we aimed at evaluating the outcomes of ESD in patients with adenomatous polyps in the colon and rectum.
Data of consecutive patients who underwent ESD for colorectal polyps from 2018 to 2021 were analyzed, retrospectively. The primary outcome of the study was the technical success of ESD. The secondary outcomes included the rate of histologically complete resection (R0), adverse events and recurrence.
Seventy patients (63.5 years, 60% males) underwent ESD for polyps in colon and rectum. A majority were located in rectum (80%) and sigmoid colon (15.7%). Narrow band classification of the polyps was Japanese Narrow Band Imaging Expert Team (JNET)-2a in 50 (71.4%) and JNET-2b in 13 (18.6%) patients. ESD was technically successful in 64 (91.4%) patients using conventional technique (72.8%) and pocket or tunnelling technique (18.6%). There were no major adverse events. Histologically RO was achieved in 58 (82.8%) patients and deep sub-mucosal invasion was noted in 12 patients. At a median follow-up of 19 (interquartile range [IQR] 15-27) months, recurrence was noticed in four (5.7%) patients all of which could be managed endoscopically.
ESD, performed at a tertiary care centre in India, yields high rates of technical success and histologically R0, with a relatively low incidence of adverse events and recurrences.
内镜下黏膜剥离术(ESD)是一种用于治疗大肠息肉的成熟内镜技术。然而,印度尚无关于ESD治疗效果的研究。在本研究中,我们旨在评估ESD治疗结肠和直肠腺瘤性息肉患者的效果。
回顾性分析2018年至2021年连续接受ESD治疗大肠息肉患者的数据。本研究的主要结局是ESD的技术成功率。次要结局包括组织学完全切除率(R0)、不良事件和复发情况。
70例患者(63.5岁,60%为男性)接受了结肠和直肠息肉的ESD治疗。大多数息肉位于直肠(80%)和乙状结肠(15.7%)。息肉的窄带分类为日本窄带成像专家组(JNET)-2a的有50例(71.4%),JNET-2b的有13例(18.6%)。使用传统技术(72.8%)和袋形或隧道技术(18.6%),64例(91.4%)患者的ESD技术成功。未发生重大不良事件。58例(82.8%)患者实现了组织学R0,12例患者出现深层黏膜下浸润。中位随访19(四分位间距[IQR] 15 - 27)个月时,4例(5.7%)患者出现复发,所有复发患者均可通过内镜处理。
在印度的一家三级医疗中心进行的ESD技术成功率高,组织学R0率高,不良事件和复发发生率相对较低。